| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2308 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2308 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2308 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2368 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2527 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2951 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3066 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3154 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3752 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4106 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4121 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4123 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4149 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4208 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4220 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4345 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4399 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4692 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4710 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4784 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5045 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5269 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5307 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5309 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5661 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6090 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6375 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6473 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6598 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6747 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7112 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7410 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7500 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7614 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7834 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7945 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8343 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8484 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9775 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9787 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9981 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.0019 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1651 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2245 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2420 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2546 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2848 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3360 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3425 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.4523 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.4668 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.4999 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.5411 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.5797 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.6693 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.7596 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.8158 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.8891 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.9620 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.9800 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.0122 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.0435 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.2991 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.3501 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.4279 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.4805 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.6140 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.8871 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.9129 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.9176 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.3906 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.8281 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 4.8105 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 5.0938 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 5.2089 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 6.0757 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 9.0244 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 9.7479 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 9.7763 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 12.8216 | Peak area | Obese neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|